Epigenetic mechanisms of Ash1L in transcriptional activation
Epigenetic mechanisms of Ash1L in transcriptional activation
批准号:
9923726
负责人:
Jin He
金额:
$33.36万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-05-01 至 2023-04-30
关键词:
ASH1L geneAddressBindingBiochemicalBiological AssayCRISPR/Cas technologyCellsComplexCryoelectron MicroscopyDevelopmentDiseaseDrosophila genusES Cell LineEnzymesEpigenetic ProcessEventGene ActivationGene ExpressionGenesGeneticGenetic TranscriptionGenetic studyHistone H3HistonesHomologous GeneImpairmentIn VitroIndividualLeadLinkLysineMLL geneMalignant NeoplasmsMammalian CellMammalsMediatingMethylationMixed-Lineage LeukemiaModelingModificationMolecularMusMutateNucleic Acid Regulatory SequencesPhenotypePlayPolycombProcessProteinsReaderResearch InstituteRoleStructureTailTimeTranscriptional Activationbasedesignembryonic stem cellepigenetic regulationgene repressiongenetic analysisgenome editinghistone methylationhistone methyltransferasehistone modificationinhibitor/antagonistmutantnew therapeutic targetnext generation sequencingpromoterrecruitstem cell differentiationtranscription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Abstract
Epigenetic modifications at transcriptional regulatory regions play an important role in facilitating lineage-specific
gene expression during stem cell differentiation. In addition to lineage-specific transcription factors,
Trithroax-group (TxG)-group proteins promote lineage-specific gene expression through antagonizing the
Polycomb-mediated transcriptional repression. In mammals, Mll1/Mll2 (Mixed Lineage Leukemia) and Ash1L
(Absent, Small, or Homeotic discs 1-Like) complexes are two TxG complexes that mediate covalent histone
modifications through their histone methyltransferase (HMTase) activities towards histone H3 lysine 4 and
histone H3 lysine 36 respectively. Although previous genetic studies have revealed that Mll1/Mll2 and Ash1L
complexes are functionally involved in a common epigenetic regulatory process, it remains unknown how these
two complexes are connected at the molecular level to carry out their functions in transcriptional activation.
Additionally, in contrast to the well-studied Mll1/Mll2 complexes and histone H3K4 methylation, the functions of
Ash1L and its mediated histone H3K36 methylation at promoters are largely unknown. In an effort to address
these fundamental questions, we purified the Ash1L-interacting proteins and identified Spindlin1 (Spin1), a
histone H3K4me3-specific reader, physically binds to Ash1L. Deletion of either Ash1L or Spin1 in mouse
embryonic stem cells impairs the expression of early lineage-specific genes upon induced differentiation,
suggesting a functional connection between Spin1 and Ash1L in cells. Built upon these results, we propose a
new model to unify the function of Mll1/Mll2 and Ash1L in transcriptional activation. In this model, Mll1/Mll2,
Spin1, and Ash1L form an epigenetic regulatory axis, in which the individual component is sequentially recruited
to the lineage-specific gene promoters to mediate histone modifications during transcriptional activation.
Specifically, Spin1 plays a central role in connecting Mll1/Mll2 and Ash1L by recruiting Ash1L to the
H3K4me3-marked lineage-specific gene promoters. To understand the functional role of individual components
in this Mll1/Mll2-Spin1-Ash1L epigenetic regulatory axis, we will combine biochemical assays, CRISPR/Cas9-
mediated genome editing, and next generation sequencing-based genetic analysis to dissect individual
regulatory step proposed in the working model. Specifically, we will determine (1) whether Ash1L and its
HMTase activity are required for its function in facilitating transcriptional activation; (2) the molecular
mechanisms for the recruitment of Ash1L to gene promoters; (3) the structural basis underlying the interaction
between Ash1L, Spin1 and histone H3K4me3. Completion of this study will not only significantly advance our
understanding on the basic epigenetic mechanisms regulating the lineage-specific gene activation, but also
reveal new therapeutic targets for blocking aberrant gene activation in cancers.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Epigenetic mechanisms of histone methyltransferase ASH1L in autism spectrum disorder
-
批准号:10743048
-
项目类别:
-
资助金额:$51.82万
-
财政年份:2023
-
负责人:Jin He
-
依托单位:
Epigenetic mechanisms of Ash1L in transcriptional activation
-
批准号:10399431
-
项目类别:
-
资助金额:$33.36万
-
财政年份:2018
-
负责人:Jin He
-
依托单位:
海外基金